China Isotope & Radiation Corp operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares China Isotope & Radiation Corp with three other
pharmaceutical manufacturers in Asia:
Shanghai Kehua Bio-Engineering Co., Ltd.
sales of 2.41 billion Chinese Renmimbi [US$348.05 million]
of which 54%
was Agent product),
MedicalSystem Biotechnology Co Ltd
(3.13 billion Chinese Renmimbi [US$451.69 million]
of which 77%
was In vitro diagnostic reagent), and
Maccura Biotechnology Co Ltd
based in CHINA
(3.22 billion Chinese Renmimbi [US$464.59 million]
of which 61%
was Agent Products).